In patients with type 2 diabetes and recent MI, colchicine reduced a composite CV outcome at 23 mo

Source CitationRoubille F, Bouabdallaoui N, Kouz S, et al. Low-dose colchicine in patients with type 2 diabetes and recent myocardial infarction in the COLchicine Cardiovascular Outcomes Trial (COLCOT). Diabetes Care. 2024;47:467-470. https://pubmed.ncbi.nlm.nih.gov/38181203/AbstractClinical Impact RatingsGIM/FP/GP: Cardiology: Endocrinology: